ALEMG — Laboratoires Euromedis SA Balance Sheet
0.000.00%
Last trade - 00:00
- €14.20m
- €3.84m
- €54.18m
- 66
- 69
- 50
- 69
2018 December 31st | R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | FAS | FAS | FAS | FAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 1.48 | 5.12 | 15.7 | 31.9 | 26.8 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 17.2 | 18.1 | 27.7 | 19.2 | 11.1 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 34.8 | 42.4 | 83.3 | 64.4 | 51.9 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 5.77 | 5.28 | 4.27 | 4.4 | 4.32 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 50.4 | 54 | 92.6 | 72.7 | 59.9 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 26 | 17.3 | 32.8 | 13.1 | 9.88 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 29.1 | 38 | 53.9 | 31.7 | 25.2 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Total Equity | 21.3 | 16 | 38.7 | 41 | 34.7 |
Total Liabilities & Shareholders' Equity | 50.4 | 54 | 92.6 | 72.7 | 59.9 |
Total Common Shares Outstanding |